These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7844443)

  • 1. [Mass-screening for ovarian cancer by transvaginal ultrasonography--study on tumor markers at the second screening].
    Sato S; Sugo T; Maruyama H; Saito Y; Hasuo Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1247-53. PubMed ID: 7844443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography--study on size of ovary to select subjects requiring second screening].
    Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1173-9. PubMed ID: 1453046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography].
    Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):683-8. PubMed ID: 1506730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mass-screening for ovarian cancer by transvaginal ultrasonography--study on ultrasonographic findings].
    Sato S; Sugo T; Maruyama H; Kunugi K; Saito Y; Hasuo Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1234-40. PubMed ID: 7844441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor marker--screening for gynecological cancer; personal experience. Utility of tumor markers in screening of ovarian cancer].
    Kimura E; Kobayashi S; Terashima Y
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2443-50. PubMed ID: 2260879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening for ovarian cancer].
    Ohmura M
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1958-63. PubMed ID: 1417004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population screening and early detection of ovarian cancer in asymptomatic women.
    Nelson AE; Francis JE; Zorbas H;
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):448-50. PubMed ID: 19780723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development and clinical research of computer aided multivariate pattern analysis system (CAMPAS) OV-1 for diagnosis of ovarian carcinoma].
    Kobayashi S; Murae M; Kimura E
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):241-8. PubMed ID: 8492011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases].
    Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
    Gan To Kagaku Ryoho; 1994 May; 21(6):823-32. PubMed ID: 8185340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening transvaginal ultrasonography of postmenopausal women in a private office setting.
    Holbert TR
    Am J Obstet Gynecol; 1994 Jun; 170(6):1699-703; discussion 1703-4. PubMed ID: 8203429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian cancer screening.
    Kurjak A; Predanic M
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunoenzymometric assay for a CA125-like antigen, CA602.
    Mochizuki H; Sato I; Nagoya K; Furusako S; Yamauchi T; Masuko H; Sato H; Morishita H; Yajima M; Sasaki H
    J Clin Lab Anal; 1992; 6(2):84-90. PubMed ID: 1383480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential markers that complement expression of CA125 in epithelial ovarian cancer.
    Rosen DG; Wang L; Atkinson JN; Yu Y; Lu KH; Diamandis EP; Hellstrom I; Mok SC; Liu J; Bast RC
    Gynecol Oncol; 2005 Nov; 99(2):267-77. PubMed ID: 16061277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
    Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546.
    Saito M; Aoki D; Susumu N; Suzuki A; Suzuki N; Udagawa Y; Nozawa S
    Int J Gynecol Cancer; 2005; 15(1):37-44. PubMed ID: 15670295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
    Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
    van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ
    Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center.
    Muto MG; Cramer DW; Brown DL; Welch WR; Harlow BL; Xu H; Brucks JP; Tsao SW; Berkowitz RS
    Gynecol Oncol; 1993 Oct; 51(1):12-20. PubMed ID: 8244166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
    Bourne TH; Campbell S; Reynolds KM; Whitehead MI; Hampson J; Royston P; Crayford TJ; Collins WP
    BMJ; 1993 Apr; 306(6884):1025-9. PubMed ID: 8490496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.